Jubilant Pharmova (formerly known as Jubilant Life Sciences) is a global integrated pharmaceutical company. The company is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses. In the Radiopharma business, the company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US. The company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. The company through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules. 

The CRDMO business of the company includes the Drug Discovery Services business that provides contract research and development services through two world class research centers in Bangalore and Noida in India and the CDMO-API business that is involved in the manufacturing of Active Pharmaceutical Ingredients. Jubilant Therapeutics (subsidiary of the company) is involved in Proprietary Novel Drugs business and is an innovative biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders. The company operates several manufacturing facilities that cater to all the regulated market including USA, Europe and other geographies.

The company was incorporated in the year 1978. It’s a public limited company domiciled in India and incorporated under the provisions of Companies Act, 1956. Its shares are listed on BSE Limited and National Stock Exchange of India Limited.

Business area of the company

The company is one of the leading Radiopharmaceutical players in the US market with a diversified portfolio spanning PET (Positron Emission Tomography) imaging, SPECT (Single Photon Emission Computed Tomography) imaging, and therapeutic products. It offers the advantage of a cost-efficient operating model supported by an on-shore manufacturing facility in Montreal, Canada, strong R&D capabilities, in-house API manufacturing, and robust supply chain management.

Business segments

• Jubilant Radiopharma
• Allergy Immunotherapy
• CDMO Sterile Injectables
• Generics
• Contract Research Development & Manufacturing Organisation
• Proprietary Novel Drugs

Awards

2012

• NDTV Profit Business Leadership Award 2012 for Corporate Social Responsibility. National Quality Excellence Award for best in Class manufacturing presented by Stars of the Industry Group.CII ‘National Award for Excellence in Water Management 2012’ as ‘Water Efficient Unit’ for Gajraula Unit.
• Economic Times - Frost & Sullivan India Manufacturing Excellence Gold Award - Process Sector for 2012. I.C.C. Award for Water Resource Management in Chemical Industry for the year 2011.

2013

• Jubilant Life Sciences Awarded ‘Excellence Award’ by Export Promotion Bureau.
• Jubilant Life Sciences declared winner of ‘Supply Chain Excellence Awards’ at 7th Express, Logistics & Supply Chain Leadership Awards 2013.
• Jubilant Life Sciences receives prestigious NDTV Profit Business Leadership Award 2012 for Corporate ‘Social Responsibility’.

2014

• Jubilant Life Sciences wins Excellence Awards at ‘India Pharma Awards’ 2014.
• BRI Partners with Jubilant Life Sciences to Bring XylamaxTM to the South Asia Poultry Market.
• Jubilant Life Sciences conferred with Golden Peacock Business Excellence Award-2014.
• Jubilant Biosys and Orion Corporation Announces Unique Collaborative Discovery Program in Pain Management Area.
• IDRI and Jubilant Chemsys Extend Research for TB Drug Discovery.
• Jubilant Life Sciences declared winner of 'Bio Excellence Award 2014' at Bangalore India Bio 2014.
• Jubilant Biosys Announces Expansion of Drug Discovery Alliance with Janssen Pharmaceutical.

2015

• Jubilant Life Sciences conferred with Golden Peacock National Quality Award.
• Jubilant Life Sciences wins ASSOCHAM’s ‘Responsible Organization Excellence’ Award 2014-15.

2016

• Sustainability Award for Best Green Process in ‘Chemical Sector’ by ‘FICCI Chemicals & Petrochemicals Awards, 2016’.
• Winner of two CHEMEXCIL Export Awards: Trishul Export Award 2012-13 and Gold Export Award 2011-12.
• 16th Annual Greentech Environment Award 2015 (Gold Category), conferred under ‘Chemicals and Pharmaceutical sector’ - Gajraula plant, India.

2017

• Social Entrepreneur of the Year (SEOY)-India Award 2017.
• Finalists for Social Entrepreneur of the Year (SEOY) India 2017 Award.
• ‘Second Awards’ under the category of Basic Inorganic, Organic Chemicals including Agro Chemicals for the outstanding export performance of the year 2015-16 by CHEMEXCIL.